Quebec Superior Court authorizes class-action lawsuit against 16 pharmaceutical firms for misleading consumers on opioid safety and addiction.
Quebec Superior Court has authorized a class-action lawsuit against 16 pharmaceutical companies, accusing them of misleading consumers about the safety and addictive nature of opioids. The lawsuit covers individuals in Quebec diagnosed with opioid use disorder since 1996 and seeks $25 million in punitive damages from each respondent and $30,000 for each member of the lawsuit. This case is separate from previous class-action settlements in Canada.
April 16, 2024
19 Articles